Sana Biotechnology, Inc.
SANANASDAQHealthcareBiotechnology
As of Oct 15, 2026 close
- Market cap
- $731.78M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $2.32$6.55
- Volume (live)
- -
- Avg. volume (3M)
- 3.99M
Sana Biotechnology (SANA) Stock Price & Financial Analysis
Sana Biotechnology Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $2.35 - $2.51 |
|---|---|
| 52-Week High | $6.55 |
| 52-Week Low | $2.32 |
| Open | $2.36 |
| Volume (last close) | 2.92M |
| Average Volume (3M) | 3.99M |
| 50-Day MA | $3.34 |
|---|---|
| 200-Day MA | $3.51 |
| 1-Year Change | −53.35% |
| Market Cap | 731.78M |
|---|---|
| Shares Outstanding | 295.67M |
| Price to Book (P/B) | 4.73 |
| EV/EBITDA | -3.99 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
Sana Biotechnology at a Glance
As of the Oct 15, 2026 close, Sana Biotechnology (SANA) has a market capitalization of $731.78M.
As of its latest reported balance sheet, it holds $57.07M in cash and securities against $73.74M of debt, a net debt position of $16.67M.
Sana Biotechnology does not currently pay a dividend.
The share price is down 53.3% over the past year. At $2.48 (the Oct 15, 2026 close) it sits near the bottom of its 52-week range of $2.32 to $6.55, below its 200-day moving average of $3.51.
Based on 6 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $8.00, 223.2% above the Oct 15, 2026 close.
Frequently Asked Questions About Sana Biotechnology
What is the current stock price for SANA?
As of the Oct 15, 2026 close, SANA stock trades at $2.48. The 52-week range is $2.32–$6.55, with a day range of $2.35–$2.51.
What is the P/E ratio for SANA?
The P/E ratio (Price-to-Earnings) for SANA is shown in the Key Statistics section. This valuation metric helps compare Sana Biotechnology, Inc. to industry peers.
Does SANA pay dividends?
Sana Biotechnology does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for SANA?
Based on ratings from 6 professional analysts over the last 90 days, the consensus for SANA is Buy. The average 12-month price target is $8.00, a 223.2% upside from the Oct 15, 2026 close of $2.48.
What is the market cap of SANA?
As of the Oct 15, 2026 close, Sana Biotechnology's market capitalization is $731.8M, classifying it as a small-cap company. Sana Biotechnology operates in the Healthcare sector within the Biotechnology industry.